Pipeline

Impact Biomedical Inc. is a wholly owned subsidiary of DSS, Inc. The company has technology assets for licensing and partnering, products for distribution and sales, and strategic investments in healthcare.

Impact Biomedical Inc. provides unique technology provider and business capabilities in addressing unmet needs in human healthcare and wellness.

in the pipeline

Biotech/Med-Tech

(FDA/EMA Regulated)

Consumer Wellness/Direct

Marketing/OTC

Technologies/Products

Core Technologies

Investments

  • Vivacitas Oncology

Summary: Impact Biomedical FDA/MedTech Pipeline U.S.

Asset Preclinical Ph I Ph II Ph III Approved IP Description
LineBacker 2029/2036 Small molecule x-bonded polyphenol compounds with potential application in neurological and inflammatory disorders.
Equivir 2036 Combination of generally recognized as safe(GRAS) polyphenols with potential application as antiviral, supplements, or medication.
Laetose™ 2029/2036 Sugar and inositol with potential to lower glycemic index, HbA1c, and beta cell protective effect as part of healthy diet.
Vivacitas Oncology
AR-67 2035-2040 Next generation Capmptothecin compound including proprietary synthesis method with potential in tough to treat cancers. Examples include recurrent glioblastoma(U.S.Orphan Drug Status), colorectal, pancreatic, ovarian, and non-small cell lung cancer.
Rubitecan TBD Camptothecin with potential oral application in late-stage pancreatic cancer.

Technologies/Products

Core Technologies

Investments

  • Biomed Precision Robotics

Summary : Impact Biomedical OTC/Consumer U.S.

Asset Description Development IP
Equivir Combination of generally recognized as safe(GRAS) polyphenols with potential application as antiviral, supplements, or medication. Marketing data/claims. 2036 Method and composition for treating influenza, Ebola, and rhinovirus
Laetose™ Sugar and inositol with potential to lower glycemic index, HbA1c, and beta cell protective effect as part of healthy diet. Marketing data/claims. $2MM Pending. Method and composition for unique combination of sugar and inositol which inhibits the inflammatory and metabolic response of sugar alone.
3F™ Combination of specialized botanical ingredients(e.g., terpenes) with potential application as insect repellent, anti-microbial, or as an additive in detergents, lotions, shampoo, fabrics and other substances Marketing data/claims. $1MM Allowed and awaiting issue as insect repellent. Pending. Antimicrobial applications.
Vivacitas Oncology Precision probiotics which optimizes probiotic formula with individual metabolism and need. Marketing data/claims. $2MM Pending. Precision match between individual and probiotics for allergy, gut, and mood.
Puradigm Products Photo-catalytic oxidation(PCO) method of air purification which is designed to simulate natures natural process indoors to actively purify air and surfaces safely, supporting a healthy lifestyle. Marketing data/claims. $TBDMM TBD